We are live on ! Find out more
INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$16.7M
DM
2
Deerfield Management
New York
$16M
SI
3
Sofinnova Investments
California
$13.8M
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$10.9M +$1.13M +131,200 +9%
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$10.9M
SCM
6
Suvretta Capital Management
New York
$6.91M +$232K +26,816 +3%
CA
7
CHI Advisors
New York
$6.08M -$244K -28,207 -3%
RSCM
8
Rock Springs Capital Management
Maryland
$5.92M +$159K +18,451 +2%
BlackRock
9
BlackRock
New York
$5.71M -$550K -63,721 -7%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$4.16M
O
11
OrbiMed
New York
$3.59M +$2.01M +232,600 +79%
Vanguard Group
12
Vanguard Group
Pennsylvania
$3.33M -$1.06M -122,466 -20%
JP Morgan Chase
13
JP Morgan Chase
New York
$2.21M -$64.8K -7,504 -2%
MB
14
MPM BioImpact
Massachusetts
$2.06M -$156K -18,109 -6%
State Street
15
State Street
Massachusetts
$1.28M -$10.1K -1,165 -0.6%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.25M -$126K -14,605 -7%
Janus Henderson Group
17
Janus Henderson Group
$857K +$1.08M +125,153 New
Northern Trust
18
Northern Trust
Illinois
$823K +$40.3K +4,661 +4%
CCM
19
CAAS Capital Management
New York
$771K -$193K -22,307 -16%
BBA
20
Baker Bros. Advisors
New York
$730K
Citadel Advisors
21
Citadel Advisors
Florida
$729K +$108K +12,512 +13%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$606K +$586K +67,884 +323%
BCM
23
Bridgeway Capital Management
Texas
$528K +$669K +77,400 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$281K +$6.72K +778 +2%
Nuveen
25
Nuveen
North Carolina
$251K -$46.6K -5,401 -11%